Project

NADPH Oxidase 1 inhibition as new therapeutic option for hepatocellular carcinoma

Code
365D04521
Duration
01 January 2022 → 31 December 2025
Funding
Funding by bilateral agreement (private and foundations)
Research disciplines
  • Medical and health sciences
    • Hepatology (incl. pancreas)
    • Immunology not elsewhere classified
    • Cancer therapy
Keywords
liver cancer NADPH oxidases humanized mice
 
Project description
No data available